NL300033I2 - Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor. - Google Patents

Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.

Info

Publication number
NL300033I2
NL300033I2 NL300033C NL300033C NL300033I2 NL 300033 I2 NL300033 I2 NL 300033I2 NL 300033 C NL300033 C NL 300033C NL 300033 C NL300033 C NL 300033C NL 300033 I2 NL300033 I2 NL 300033I2
Authority
NL
Netherlands
Prior art keywords
menopausal
peri
post
disorders
multiple package
Prior art date
Application number
NL300033C
Other languages
English (en)
Other versions
NL300033I1 (nl
Original Assignee
Pre Jay Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27060286&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300033(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pre Jay Holdings Ltd filed Critical Pre Jay Holdings Ltd
Publication of NL300033I1 publication Critical patent/NL300033I1/nl
Publication of NL300033I2 publication Critical patent/NL300033I2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
NL300033C 1983-08-05 2001-01-04 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor. NL300033I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52083483A 1983-08-05 1983-08-05
US06/635,236 US4826831A (en) 1983-08-05 1984-07-27 Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens

Publications (2)

Publication Number Publication Date
NL300033I1 NL300033I1 (nl) 2001-03-01
NL300033I2 true NL300033I2 (nl) 2004-04-01

Family

ID=27060286

Family Applications (5)

Application Number Title Priority Date Filing Date
NL970026C NL970026I1 (nl) 1983-08-05 1997-07-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL970037C NL970037I2 (nl) 1983-08-05 1997-10-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.
NL980038C NL980038I2 (nl) 1983-08-05 1998-11-20 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL300022C NL300022I2 (nl) 1983-08-05 2000-10-23 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.
NL300033C NL300033I2 (nl) 1983-08-05 2001-01-04 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
NL970026C NL970026I1 (nl) 1983-08-05 1997-07-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL970037C NL970037I2 (nl) 1983-08-05 1997-10-22 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.
NL980038C NL980038I2 (nl) 1983-08-05 1998-11-20 Werkwijze voor hormonale behandeling van peri-menopausale, meno-pausale en post-menopausale stoornissen en een meervoudig preparatenpakket daarvoor.
NL300022C NL300022I2 (nl) 1983-08-05 2000-10-23 Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervoudige preparatenpakket daarvoor.

Country Status (12)

Country Link
US (2) US4826831A (nl)
EP (1) EP0136011B2 (nl)
AT (1) ATE147987T1 (nl)
CA (1) CA1240927A (nl)
DE (5) DE10075037I2 (nl)
DK (2) DK165390C (nl)
IL (1) IL72556A (nl)
LU (5) LU90107I2 (nl)
MX (1) MX9203720A (nl)
NL (5) NL970026I1 (nl)
NZ (1) NZ209066A (nl)
PH (1) PH24052A (nl)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961931A (en) * 1982-07-29 1990-10-09 Alza Corporation Method for the management of hyperplasia
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
CH674618A5 (nl) * 1987-04-02 1990-06-29 Ciba Geigy Ag
ES2024010B3 (es) * 1987-07-06 1992-02-16 Akzo Nv Unidad de dosis farmaceutica.
US4900734A (en) * 1987-08-27 1990-02-13 Maxson Wayne S Novel pharmaceutical composition containing estradiol and progesterone for oral administration
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
EP0322020A1 (en) * 1987-12-22 1989-06-28 Akzo N.V. Pharmaceutical dosage unit for treating climacteric complaints and osteoporosis
HUT52382A (en) * 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
ATE128362T1 (de) * 1989-03-10 1995-10-15 Endorecherche Inc Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
US5043331A (en) * 1989-06-15 1991-08-27 Orion-Yhtyma Oy Treatment of postmenopausal disorders
HU222501B1 (hu) * 1991-06-28 2003-07-28 Endorecherche Inc. MPA-t vagy MGA-t tartalmazó nyújtott hatóanyag-felszabadulású gyógyászati készítmény és eljárás előállítására
ZA924811B (en) * 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
US6037339A (en) * 1993-02-08 2000-03-14 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
ZA94715B (en) * 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
US5710144A (en) * 1993-02-08 1998-01-20 Akzo Nobel N.V. C-11 substituted steroids for treating menopausal complaints
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
DE19510861A1 (de) * 1995-03-16 1996-09-19 Schering Ag Einmonatsspritze als Depot-Kontrazeptivum und für die Hormonersatztherapie für peri- und praemenopausale Frauen
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
US5654011A (en) * 1996-07-30 1997-08-05 Energetics, Inc. Dietary supplements
US5807586A (en) * 1996-07-30 1998-09-15 Energetics, Inc. Method of dietary supplementation
US6040333A (en) * 1996-07-30 2000-03-21 Energetics, Inc. Dietary supplements
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE19739916C2 (de) 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
WO2000003678A2 (en) * 1998-07-17 2000-01-27 Pharmacia & Upjohn Company Subcutaneous medroxyprogesterone acetate for contraception
US6165504A (en) * 1998-09-23 2000-12-26 Barr Laboratories, Inc. Methods for treating hot flashes and improving the quality of life of castrated prostatic cancer patients
BR9906862A (pt) * 1998-10-09 2001-11-27 Upjohn Co Uso de uma quantidade eficaz de um agente desubstituição hormonal para o tratamento demenopausa humana e de endometriose
US6613758B1 (en) 1999-04-02 2003-09-02 Barr Laboratories, Inc. Method for treating osteoporosis in castrated prostatic cancer patients
US6703367B1 (en) 1999-04-27 2004-03-09 Praecis Pharmaceuticals Inc. Methods for treating hot flashes and gynaecomastia
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
US7025979B2 (en) 2000-02-15 2006-04-11 Schering Ag Male contraceptive formulation comprising norethisterone
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US20010034340A1 (en) * 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
US20020151530A1 (en) * 2000-12-22 2002-10-17 Leonard Thomas W. Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
DE10100911A1 (de) * 2001-01-11 2002-08-01 Schering Ag Verfahren zur Hormonersatztherapie und dessen Darreichungsform
US20060142257A1 (en) * 2001-01-19 2006-06-29 Eberhard Nieschlag Male contraceptive formulation comprising norethisterone
MXPA03008366A (es) * 2001-03-16 2004-11-12 Wyeth Corp Terapia de reemplazamiento de estrogenos.
EA200301022A1 (ru) * 2001-03-16 2004-02-26 Уайт Гормональная заместительная терапия
US20130203722A1 (en) 2006-09-26 2013-08-08 Rhonda R. Voskuhl Estriol therapy for autoimmune and neurodegenerative disease and disorders
WO2008150547A1 (en) 2007-06-04 2008-12-11 The Regents Of The University Of California Pregnancy hormone combination for treatment of autoimmune diseases
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
CA2446849A1 (en) 2001-05-16 2002-11-21 Endeavor Pharmaceuticals Treatment of conditions relating to hormone deficiencies by administration of progestins
WO2003006027A1 (en) * 2001-07-13 2003-01-23 Schering Aktiengesellschaft Combination of drospirenone and an estrogen sulphamate for hrt
WO2003018026A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
BRPI0214716B8 (pt) 2001-12-05 2021-05-25 Teva Womens Health Inc kit, preparos, e uso de estrogênio e progestina na fabricação de um medicamento para uso na prevenção de gravidez
US20030191096A1 (en) * 2002-04-03 2003-10-09 Leonard Thomas W. Method of hormonal therapy
AU2003210759B2 (en) * 2002-04-03 2007-01-25 Barr Laboratories, Inc. Step-down estrogen therapy
TW200306851A (en) * 2002-04-29 2003-12-01 Wyeth Corp Hormone replacement therapy
TW200400040A (en) * 2002-05-17 2004-01-01 Wyeth Corp Hormone replacement therapy
TW200404551A (en) * 2002-05-17 2004-04-01 Wyeth Corp Hormone replacement therapy
NZ538342A (en) * 2002-08-28 2007-08-31 Robert Casper Estrogen replacement regimen
EP1462106A1 (en) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmaceutical compositions and kits comprising 17-beta-estradiol and a progesteron for the treatment of gynecological disorders
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
MXPA05010871A (es) * 2003-04-11 2005-11-25 Barr Lab Inc Metodos para administrar estrogenos y progestinas.
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
CA2532089C (en) * 2003-07-16 2012-05-22 Duramed Pharmaceuticals, Inc. Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
ES2482104T3 (es) 2003-09-29 2014-08-01 Novo Nordisk Femcare Ag Formulaciones HRT
WO2005030176A1 (en) * 2003-09-29 2005-04-07 Novo Nordisk Femcare Ag Improved stability of progestogen formulations
BRPI0511569A (pt) * 2004-05-26 2008-01-02 Wyeth Corp composições e métodos para o tratamento de distúrbio disfórico pré-menstrual
DE102004026679A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026669A1 (de) * 2004-05-28 2005-12-15 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
US20070111975A1 (en) * 2004-10-07 2007-05-17 Duramed Pharmaceuticals, Inc. Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens
CA2601773A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP2289487A1 (en) * 2005-12-27 2011-03-02 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
AR065816A1 (es) * 2007-03-26 2009-07-01 Theramex Regimen anticonceptivo oral
CN102985070A (zh) 2010-04-15 2013-03-20 拜耳知识产权有限责任公司 用于hrt的极低剂量的固体口服剂型
JP6285866B2 (ja) 2011-11-23 2018-02-28 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然複合ホルモン補充製剤および療法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
WO2015168000A1 (en) * 2014-04-28 2015-11-05 The Regents Of The University Of California Estrogen combination for treatment of multiple sclerosis
ES2959603T3 (es) 2014-04-28 2024-02-27 Univ California Envase farmacéutico para terapia con estriol para el tratamiento de la esclerosis múltiple
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10821117B2 (en) 2014-09-02 2020-11-03 The Regents Of The University Of California Estrogen therapy for brain gray matter atrophy and associated disability
WO2016053946A1 (en) 2014-09-29 2016-04-07 The Regents Of The University Of California Compositions and methods for maintaining cognitive function
EP3277285A4 (en) 2015-03-30 2018-12-19 The Regents of the University of California Methods of monitoring estriol therapy
GEP20217308B (en) 2015-06-18 2021-10-25 Estetra Sprl Orodispersible dosage unit containing an estetrol component
CU24504B1 (es) 2015-06-18 2021-04-07 Estetra Sprl Unidad de dosificación orodispersable que contiene un componente estetrol y un proceso que incluye un paso de granulación para preparar el mismo
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
KR20220144885A (ko) 2016-08-05 2022-10-27 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639600A (en) * 1969-08-28 1972-02-01 Upjohn Co Process of establishing cyclicity in a human female
US3733407A (en) * 1971-08-25 1973-05-15 Syntex Corp Menopause treatment
US3836651A (en) * 1972-02-22 1974-09-17 Biolog Concepts Inc Novel oral contraceptive combination
DE2365103C3 (de) * 1973-12-21 1980-08-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen V erwendung von Hormonen zur Kontrazeption
US4018919A (en) * 1975-07-16 1977-04-19 Eli Lilly And Company Sequential contraceptive method using two types of progestational agents
DE2645307A1 (de) * 1976-10-05 1978-04-06 Schering Ag Neue mittel und neue methoden zur behandlung klimakterischer ausfallerscheinungen
GB1578340A (en) * 1977-11-15 1980-11-05 Normalair Garrett Ltd Mechanical hands eg for diving apparatus
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms

Also Published As

Publication number Publication date
DE10199001I2 (de) 2010-07-08
NL980038I2 (nl) 2005-06-01
US4826831A (en) 1989-05-02
DK377084D0 (da) 1984-08-03
NL970026I1 (nl) 1997-10-01
LU90697I2 (fr) 2001-02-13
NL300033I1 (nl) 2001-03-01
LU90107I2 (fr) 1997-12-17
MX9203720A (es) 1992-07-31
NL300022I1 (nl) 2001-01-02
NL970037I2 (nl) 2004-04-01
IL72556A (en) 1989-05-15
NL300022I2 (nl) 2004-04-01
DK377084A (da) 1985-02-06
DE10199001I1 (de) 2002-03-14
EP0136011A2 (en) 1985-04-03
DE3486442T3 (de) 2005-05-12
DE19775086I2 (de) 2001-08-23
NZ209066A (en) 1988-01-08
LU90696I2 (fr) 2001-02-13
NL970037I1 (nl) 1998-02-02
CA1240927A (en) 1988-08-23
DE3486442D1 (de) 1997-03-06
EP0136011A3 (en) 1986-07-16
LU90343I2 (fr) 1999-03-29
DE10199010I1 (de) 2002-05-08
DE10199010I2 (de) 2010-01-28
IL72556A0 (en) 1984-11-30
PH24052A (en) 1990-03-05
DK175317B1 (da) 2004-08-16
LU91096I2 (fr) 2004-11-30
DE10075037I2 (de) 2010-01-28
NL980038I1 (nl) 1999-02-01
ATE147987T1 (de) 1997-02-15
DK165390B (da) 1992-11-23
DE10075037I1 (de) 2001-03-01
DK200400365A (da) 2004-03-04
EP0136011B1 (en) 1997-01-22
EP0136011B2 (en) 2004-06-09
DE3486442T2 (de) 1997-06-05
DK165390C (da) 2004-04-26
USRE36247E (en) 1999-07-06

Similar Documents

Publication Publication Date Title
NL300022I1 (nl) Werkwijze voor hormonale behandeling van peri-menopausale, menopausale en post-menopausale stoornissen en een meervourdig preparatenpakket daarvoor.
NL186151B (nl) Werkwijze voor het afscheiden van niet-vertakte alkanen uit een uitgangsmengsel dat niet-vertakte alkanen, vertakte alkanen en aromatische koolwaterstoffen bevat.
NL7709982A (nl) Werkwijze voor het winnen van reagentia en produkten uit een afvalwaterstroom.
NL193632B (nl) Werkwijze en inrichting voor het afscheiden van een gas uit een gasmengsel.
NL170423B (nl) Werkwijze voor de bereiding van een onvertakte polyester en voorwerp, vervaardigd uit deze polyester.
NL7503721A (nl) Werkwijze voor het afscheiden van een in hoofd- zaak uit waterstof bestaand recirculaatgas van de effluent afkomstig van een werkwijze voor het behandelen van koolwaterstoffen bij aanwe- zigheid van waterstof.
JPS5219541A (en) Accelerated fixing device
JPS5231266A (en) Fixing method of stud-bolt for rake booster body
JPS51142308A (en) Decorative frame fitting device for speaker system
JPS51128211A (en) Synthesizer for receiver
JPS5281865A (en) Apparatus for separating and conveying sheets and method of executing the same
JPS5322241A (en) Branching and joining structure in overhead cableway s ystem
JPS5361862A (en) Method and apparatus for separating and transferring plate likearticles
JPS5225291A (en) Fixing or tightening fittings for wire, etc.
JPS5264710A (en) Apparatus for pulling up vehicle in gravity acceleration transporting system
FR2537145B1 (fr) Procede pour separer la 4-androstene-3,17-dione et la 1,4-androstadiene-3, 17-dione
JPS51127959A (en) Fixing support method for pipe etc
JPS521807A (en) Noise reducing apparatus of railway vehicle
PL129422B2 (en) Process for preparing testosterone and 5-alpha-androstane-3,17-dione from androstenedione
JPS51138841A (en) Dc feed system